Strategic Intelligence: Regenerative Medicine (2025)
Summary
Regenerative medicine is a transformative area of healthcare focused on curing disease, eliminating cancer, and restoring damaged or aging tissues through gene therapy, cell therapy, and tissue repair. These therapies aim to restore biological function by correcting genetic defects, rebalancing cellular environments, or replacing damaged tissues.
Scope
- Regenerative medicine can transform healthcare.
- Applications span multiple therapeutic areas.
- Gene therapies currenlty focus on rare diseases, with expansion into common and polygenic conditions.
- Understand what regenerative medicine is and how it can reshape the medical devices industry.
- Learn who the leaders and challengers are within the regenerative medicine theme.
- Understand the trends that are currently and will continue to impact regenerative medicine theme.
- Executive Summary
- Players
- Technology Briefing
- Gene therapy
- Cell therapy
- Tissue repair
- Trends
- Technology trends
- Macroeconomic trends
- Regulatory trends
- Industry Analysis
- Market size and growth forecasts
- Gene therapy
- Cell therapy
- Tissue repair
- Timeline
- Value Chain
- Gene therapies
- Tissue repair
- Cell therapies
- Companies
- Public companies
- Private companies
- Sector Scorecard
- Medical devices sector scorecard
- Who’s who
- Thematic screen
- Valuation screen
- Risk screen
- Glossary
- Further Reading
- GlobalData reports
- Our Thematic Research Methodology
- About GlobalData
- Contact Us
- List of Tables
- Table 1: Technology trends
- Table 2: Macroeconomic trends
- Table 3: Regulatory trends
- Table 4: Public companies
- Table 5: Private companies
- Table 6: Glossary
- Table 7: GlobalData reports
- List of Figures
- Figure 1: Who are the leading players in the regenerative medicine theme, and where do they sit in the value chain?
- Figure 2: The global gene therapy market is expected to reach sales of $59.1 billion by 2030
- Figure 3: The global cell therapy market is expected to reach sales of $88.7 billion by 2030
- Figure 4: Approximately 800,000 people have heart failures every year in the US
- Figure 5: The regenerative medicine story
- Figure 6: The regenerative medicine value chain
- Figure 7: The regenerative medicine value chain - Gene therapies
- Figure 8: The regenerative medicine value chain - Tissue repair
- Figure 9: The regenerative medicine value chain - Cell therapies
- Figure 10: Who does what in the medical devices space?
- Figure 11: Thematic screen
- Figure 12: Valuation screen
- Figure 13: Risk screen
- Figure 14: Our five-step approach for generating a sector scorecard
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook